Skip to main content
Log in

Immunopharmacology of human mast cells and basophils

  • Review
  • Published:
International Journal of Clinical and Laboratory Research

Abstract

Human mast cells and basophils play a key role in the pathogenesis of several immunological and inflammatory disorders, not only by producing inflammatory and fibrogenic mediators, but also by directly (CD40 ligand) and indirectly secreting various cytokines and chemokines. Studies carried out to evaluate the effects of drugs that modulate the release of mediators and cytokines from these cells have contributed to clarifying the biochemical mechanism by which immunological and non-immunological stimuli activate these cells. Significant differences have been documented between human mast cells and basophils as regard the pharmacological agents that modulate the release of mediators, between mast cells isolated from different anatomical sites, and between compounds of the same class of drugs. Efforts to gain insight into the biochemical events occurring during immunological activation of mast cells and basophils could lead to the identification of new biochemical targets for therapeutic interventions in several immunological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Naclerio RM, Proud D, Togias AG, Atkinson NF Jr, Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, Lichtenstein LM. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65.

    PubMed  CAS  Google Scholar 

  2. Casolaro V, Spadaro G, Marone G. Human basophil releasability. VI. Changes in basophil releasbility in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990; 142: 1108.

    PubMed  CAS  Google Scholar 

  3. Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, Valentine MD, Permutt S, Lichtenstein LM. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66: 1072.

    Article  PubMed  CAS  Google Scholar 

  4. Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G. Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation 1986; 6: 1175.

    Google Scholar 

  5. Marone G, Giordano A, Cirillo R, Triggiani M, Vigorito C. Cardiovascular and metabolic effects of peptide leukotrienes in man. Ann N Y Acad Sci 1988; 524: 321.

    Article  PubMed  CAS  Google Scholar 

  6. Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976; 67: 305.

    Article  PubMed  Google Scholar 

  7. Marone G, Giugliano R, Lembo G, Ayala F. Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. J Invest Dermatol 1986; 87: 19.

    Article  PubMed  CAS  Google Scholar 

  8. Casolaro V, Galeone D, Giacummo A, Sanduzzi A, Melillo G, Marone G. Human basophil/mast cell releasability. V. Functional comparison of cells obtained from peripheral blood, lung parenchyma and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989; 139: 1375.

    PubMed  CAS  Google Scholar 

  9. Kimura I, Tanizaki Y, Saito K, Takahashi K, Ueda N, Sato S. Appearance of basophils in the sputum of patients with bronchial asthma. Clin Allergy 1975; 5: 95.

    Article  PubMed  CAS  Google Scholar 

  10. Guo C-B, Liu MC, Galli SJ, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Identification of IgE-bearing cells in the late-phase response to antigen in the lung as basophils. Am J Respir Cell Mol Biol 1994; 10: 384.

    PubMed  CAS  Google Scholar 

  11. Dvorak AM, Mihm MC Jr, Dvorak HF. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol 1976; 116: 687.

    PubMed  CAS  Google Scholar 

  12. Connel JT. Asthmatic deaths. Role of the mast cell. JAMA 1971; 215: 769.

    Article  Google Scholar 

  13. Koshino T, Teshima S, Fukushima N, Takaishi T, Hirai K, Miyamoto Y, Arai Y, Sano Y, Ito K, Morita Y. Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 1993; 23: 919.

    Article  PubMed  CAS  Google Scholar 

  14. Natbony SF, Philips ME, Elias JM, Godfrey HP, Kaplan AP. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 1983; 71: 177.

    Article  PubMed  CAS  Google Scholar 

  15. Kern F, Lichtenstein LM. Defective histamine release in chronic urticaria. J Clin Invest 1976; 57: 1369.

    Article  PubMed  CAS  Google Scholar 

  16. Kovanen PT. Role of mast cells in atherosclerosis. In: Marone G, ed. Human basophils and mast cells: clinical aspects. Basel: Karger; 1995; 132–170.

    Google Scholar 

  17. Patella V, Marinò I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M, Marone G. Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998.

  18. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995; 154: 2855.

    PubMed  CAS  Google Scholar 

  19. Patella V, de Crescenzo G, Marinò I, Genovese A, Adt M, Gleich GJ, Marone G. Eosinophil granule proteins activate human heart mast cells. J Immunol 1996; 157: 1219.

    PubMed  CAS  Google Scholar 

  20. de Paulis A, Marinò I, Ciccarelli A, de Crescenzo G, Concardi M, Verga L, Arbustini E, Marone G. Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum 1996; 39: 1222.

    Article  PubMed  Google Scholar 

  21. de Paulis A, Ciccarelli A, Marinò I, de Crescenzo G, Marinò D, Marone G. Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. Arthritis Rheum 1997; 40: 469.

    Article  PubMed  Google Scholar 

  22. Athreya BH, Moser G, Raghavan TES. Increased circulating basophils in juvenile rheumatoid arthritis. A preliminary report. Am J Dis Child 1975; 129: 935.

    PubMed  CAS  Google Scholar 

  23. Seibold JR, Giorno RC, Claman HN. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum 1990; 33: 1702.

    Article  PubMed  CAS  Google Scholar 

  24. de Paulis A, Valentini G, Spadaro G, Lupoli S, Tirri G, Marone G. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma. Arthritis Rheum 1991; 34: 1289.

    Article  PubMed  Google Scholar 

  25. Chanez P, Lacoste J-Y, Guillot B, Giron J, Barnèon G, Enander I, Godard P, Michel F-B, Bousquet J. Mast cells’ contribution to the fibrosing alveolitis of the scleroderma lung. Am Rev Respir Dis 1993; 147: 1497.

    PubMed  CAS  Google Scholar 

  26. Kawanami O, Ferrans VJ, Fulmer JD, Crystal RG. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest 1979; 40: 717.

    PubMed  CAS  Google Scholar 

  27. Dvorak AM, Monahan RA, Osage JE, Dickersin GR. Crohn’s disease: transmission electron microscopic studies. II. Immunologic inflammatory response: alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol 1980; 11: 606.

    Article  PubMed  CAS  Google Scholar 

  28. Mochizuki M, Kuwabara T, Chan C-C, Nussenblatt RB, Metcalfe DD, Gery I. An association between susceptibility to experimental autoimmune uveitis and choroidal mast cell numbers. J Immunol 1984; 133: 1699.

    PubMed  CAS  Google Scholar 

  29. de Kozak Y, Sainte-Laudy J, Benveniste J, Faure J-P. Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis. Eur J Immunol 1981; 11: 612.

    Article  PubMed  Google Scholar 

  30. Colvin RB, Dvorak AM, Dvorak HF. Mast cells in the cortical tubular epithelium and interstitium in renal disease. Hum Pathol 1974; 5: 315.

    PubMed  CAS  Google Scholar 

  31. Colvin RB, Dvorak HF. Basophils and mast cells in renal allograft rejection. Lancet 1974; I: 212.

    Article  Google Scholar 

  32. Marone G, Casolaro V, Cirillo R, Stellato C, Genovese A. Pathophysiology of human basophils and mast cells in allergic disorders. Clin Immunol Immunopathol 1989; 50: S24.

  33. Bradding P, Feather IH, Howart PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Churg MK, Holgate ST. Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992; 176: 1381.

    Article  PubMed  CAS  Google Scholar 

  34. Möller A, Lippert U, Lessmann D, Kolde G, Hamann K, Welker P, Schadendorf D, Rosenbach T, Luger T, Czarnetzki BM. Human mast cells produce IL-8. J Immunol 1993; 151: 3261.

    PubMed  Google Scholar 

  35. MacGlashan DW Jr, White JM, Huang S-K, Ono SJ, Schroeder JT, Lichtenstein LM. Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 1994; 152: 3006.

    PubMed  CAS  Google Scholar 

  36. Li HL, Sim TC, Alam R. IL-13 released by and localized in human basophils. J Immunol 1996; 156: 4833.

    PubMed  CAS  Google Scholar 

  37. Patterson R, McKenna JM, Suszko IM, Solliday NH, Pruzansky JJ, Roberts M, Kehoe TJ. Living histamine-containing cells from the bronchial lumens of humans: description and comparison of histamine content with cells of Rhesus monkeys. J Clin Invest 1977; 59: 217.

    Article  PubMed  CAS  Google Scholar 

  38. Tomioka M, Ida S, Shindoh Y, Ishihara T, Takishima T. Mast cells in bronchoalveolar lumen of patients with bronchial asthma. Am Rev Respir Dis 1984; 129: 1000.

    PubMed  CAS  Google Scholar 

  39. Liu MC, Hubbard WC, Proud D, Stealey BA, Galli SJ, Kagey-Sobotka A, Bleecker ER, Lichtenstein LM. Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Am Rev Respir Dis 1991; 144: 51.

    PubMed  CAS  Google Scholar 

  40. Brinkman GL. The mast cell in normal human bronchus and lung. J Ultrastruct Res 1968; 23: 115.

    Article  PubMed  CAS  Google Scholar 

  41. Patterson R, Head LR, Suszko IM, Zeiss CR Jr. Mast cells from human respiratory tissue and their in vitro reactivity. Science 1972; 175: 1012.

    Article  PubMed  CAS  Google Scholar 

  42. Crimi E, Chiaramondia M, Milanese M, Rossi GA, Brusasco V. Increase of mast cell numbers in mucosa after the late-phase asthmatic response to allergen. Am Rev Respir Dis 1991; 144: 1282.

    PubMed  CAS  Google Scholar 

  43. Sparrow D, O’Connor T, Rosner B, Weiss TS. Predictors of longitudinal change in methacoline airways responsiveness among middle-aged and older men: the normative aging study. Am J Respir Crit Care Med 1994; 149: 376.

    PubMed  CAS  Google Scholar 

  44. Pin I, Freitag AP, O’Byrne PM, Girgis-Gabardo A, Watson RM, Dolovich J, Denburg JA, Hargreave FE. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145: 1265.

    PubMed  CAS  Google Scholar 

  45. Bédard PM, Brunet C, Pelletier G, Hébert J. Increased compound 48/80 induced local histamine release from non-lesional skin of patients with chronic urticaria. J Allergy Clin Immunol 1986; 78: 1121.

    Article  PubMed  Google Scholar 

  46. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993; 177: 605.

    Article  PubMed  CAS  Google Scholar 

  47. Ochsensberger B, Daepp GC, Rihs S, Dahinden CA. Human blood basophils produce interleukin-13 in response to IgE-receptor-dependent and -independent activation. Blood 1996; 88: 3028.

    Google Scholar 

  48. Li H, Sim TC, Grant JA, Alam R. The production of macrophage inflammatory protein-1α by human basophils. J Immunol 1996; 157: 1207.

    PubMed  CAS  Google Scholar 

  49. Ohkawara Y, Yamauchi K, Tanno Y, Tamura G, Ohtani H, Nagura H, Ohkuda K, Takishima T. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-α in sensitized lung tissue after IgE receptor triggering. Am Rev Respir Cell Mol Biol 1992; 7: 385.

    CAS  Google Scholar 

  50. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST. Interleukin-4,-5 and -6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10: 471.

    PubMed  CAS  Google Scholar 

  51. Burd PR, Thompson WC, Max EE, Mills FC. Activated mast cells produce interleukin 13. J Exp Med 1995; 181: 1373.

    Article  PubMed  CAS  Google Scholar 

  52. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on cytokine content. J Immunol 1995; 155: 297.

    PubMed  CAS  Google Scholar 

  53. Krüger-Krasagakes S, Möller A, Kolde G, Lippert U, Weber M, Henz BM. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996; 106: 75.

    Article  PubMed  Google Scholar 

  54. Marone G, Casolaro V, Patella V, Florio G, Triggiani M. Molecular and cellular biology of mast cells and basophils. Int Arch Allergy Immunol 1997; 114: 207.

    PubMed  CAS  Google Scholar 

  55. Rumsaeng V, Cruikshank WW, Foster B, Prussin C, Kirshenbaum AS, Davis TA, Kornfeld H, Center DM, Metcalfe DD. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 1997; 159: 2904.

    PubMed  CAS  Google Scholar 

  56. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasei H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Bonnefoy JY. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 1993; 365: 340.

    Article  PubMed  CAS  Google Scholar 

  57. Dvorak AM, Galli SJ, Schulman ES, Lichtenstein LM, Dvorak HF. Basophil and mast cell degranulation: ultrastructural analysis of mechanism of mediator release. Fed Proc 1983; 42: 2510.

    PubMed  CAS  Google Scholar 

  58. Dvorak AM. Ultrastructural analysis of human mast cells and basophils. In: Marone G, ed. Human basophils and mast cells: biological aspects. Basel: Karger; 1995: 1–33.

    Google Scholar 

  59. Triggiani M, Oriente A, Seeds MC, Bass DA, Marone G, Chilton FH. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J Exp Med 1995; 182: 1181.

    Article  PubMed  CAS  Google Scholar 

  60. Nilsson G, Miettinen U, Ishizaka T, Ashman LK, Irani AM, Schwartz LB. Interleukin-4 inhibits the expression of kit and tryptase during stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 1994; 84: 1519.

    PubMed  CAS  Google Scholar 

  61. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washing during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis 1988; 138: 406.

    PubMed  CAS  Google Scholar 

  62. Marone G, Cirillo R, Genovese A, Marino O, Quattrin S. Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion. Life Sci 1989; 45: 1745.

    Article  PubMed  CAS  Google Scholar 

  63. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Normal PS, Lichtenstein LM. Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J Clin Invest 1989; 83: 1519.

    Article  PubMed  CAS  Google Scholar 

  64. Charlesworth EN. The role of basophils and mast cells in acute and late reactions in the skin. Allergy 1997; 52 [Suppl 34]: 31.

    PubMed  CAS  Google Scholar 

  65. Iliopoulos O, Baroody FM, Naclerio RM, Bochner BS, Kagey-Sobotka A, Lichtenstein LM. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol 1992; 148: 2223.

    PubMed  CAS  Google Scholar 

  66. de Paulis A, Cirillo R, Ciccarelli A, Condorelli M, Marone G. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human FcεRI+ cells. J Immunol 1991; 146: 2374.

    PubMed  Google Scholar 

  67. de Paulis A, Cirillo R, Ciccarelli A, de Crescenzo G, Oriente A, Marone G. Characterization of the anti-inflammatory effect of FK-506 on human mast cells. J Immunol 1991; 147: 4278.

    PubMed  Google Scholar 

  68. de Paulis A, Ciccarelli A, de Crescenzo G, Cirillo R, Patella V, Marone G. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation byN-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol 1996; 98: 152.

    Article  PubMed  Google Scholar 

  69. Marone G. Immunosuppressive treatment of chronic asthma. In: Lichtenstein LM, Fauci AS, eds. Current therapy in allergy, immunology, and rheumatology. Toronto: Decker; 1992: 368–371.

    Google Scholar 

  70. Casolaro V, Spadaro G, Patella V, Marone G. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. J Immunol 1993; 151: 5563.

    PubMed  CAS  Google Scholar 

  71. Marone G, de Paulis A, Casolaro V, Ciccarelli A, Spadaro G, Patella V, Stellato C, Cirillo R, Genovese A. Are the anti-inflammatory properties of cyclosporin A useful in the treatment of chronic asthma? In: Melillo G, O’Byrne PM, Marone G, eds. Respiratory allergy. Advances in clinical immunology and pulmonary medicine. Amsterdam: Elsevier; 1993: 251–260.

    Google Scholar 

  72. Lichtenstein LM, Margolis S. Histamine release in vitro. Inhibition by catecholamines and methylxanthines. Science 1968; 161: 902.

    Article  PubMed  CAS  Google Scholar 

  73. Chan SC, Li S-H, Hanifin JM. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 1993; 100: 681.

    Article  PubMed  CAS  Google Scholar 

  74. Giembycz MA. Phosphodiesterase 4 and tolerance toβ 2-adrenoreceptor agonists in asthma. Trends Pharmacol Sci 1996; 17: 331.

    Article  PubMed  CAS  Google Scholar 

  75. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725.

    PubMed  CAS  Google Scholar 

  76. Müller T, Engles P, Fozard JR. Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition. Trends Pharmacol Sci 1996; 17: 294.

    Article  PubMed  Google Scholar 

  77. Columbo M, Horowitz E, McKenzie-White J, Kagey-Sobotka A, Lichtenstein LM. Pharmacologic control of histamine release from human basophils induced by platelet activating factor. Int Arch Allergy Immunol 1993; 102: 383.

    PubMed  CAS  Google Scholar 

  78. Peachell PT, Undem BJ, Schleimer RP, MacGlashan DW Jr, Lichtenstein LM, Cieslinski LB, Torphy TJ. Preliminary identification and role of phosphodiesterase isozymes in human basophils. J Immunol 1992; 148: 2503.

    PubMed  CAS  Google Scholar 

  79. Marone G, Columbo M, Triggiani M, Cirillo R, Genovese A, Formisano S. Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. Biochem Pharmacol 1987; 36: 13.

    Article  PubMed  CAS  Google Scholar 

  80. Torphy TJ, Livi GP, Balcarek JR, White FH, Chilton FH, Undem BJ. Therapeutic potential of isozyme-selective phosphodiesterase inhibitors in the treatment of asthma. Adv Second Messenger Phosphoprotein Res 1991; 25: 289.

    Google Scholar 

  81. Essayan DM, Huang S-K, Kagey-Sobotka A, Lichtenstein LM. Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression. J Allergy Clin Immunol 1997; 99: 28.

    PubMed  CAS  Google Scholar 

  82. Balibrea-Cantero JL, Arias-Diaz J, Garcia C, Torres-Melero J, Simon C, Rodriguez JM, Vara E. Effect of pentoxifylline on the inhibition of surfactant synthesis induced by TNF-α in human type II pneumocytes. Am J Respir Crit Care Med 1994; 149: 699.

    PubMed  CAS  Google Scholar 

  83. Yasui K, Komiyama A, Molski TFP, Sha’afi RI. Pentoxyfil-line and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions. Infect Immun 1994; 62: 922.

    PubMed  CAS  Google Scholar 

  84. Marone G, Ambrosio G, Bonaduce D, Genovese A, Triggiani M, Condorelli M. Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. Int Arch Allergy Appl Immunol 1984; 74: 356.

    PubMed  CAS  Google Scholar 

  85. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981–83: case-control study. Lancet 1989; I: 917.

    Article  Google Scholar 

  86. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockroft D, Boivin J-F, McNutt M, Buist AS, Rebuck AS. The use ofβ-agonist and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501.

    PubMed  CAS  Google Scholar 

  87. Nials AT, Ball DI, Butchers PR, Coleman RA, Humbless AA, Johnson M, Vardey CJ. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur J Pharmacol 1994; 251: 127.

    Article  PubMed  CAS  Google Scholar 

  88. Stevenson DD, Simon RA. Sensitivity to aspirin and non-steroidal antiinflammatory drugs. In: Middleton EE, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy. Principles and practice. St. Louis: Mosby; 1993: 1747–1765.

    Google Scholar 

  89. Marone G, Kagey-Sobotka A, Lichtenstein LM. Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. J Immunol 1979; 123: 1669.

    PubMed  CAS  Google Scholar 

  90. Marone G, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated histamine release from human basophils: differences between antigen E- and anti-IgE-induced secretion. Int Arch Allergy Appl Immunol 1981; 65: 339.

    PubMed  CAS  Google Scholar 

  91. Marone G, Columbo M, Cirillo A, Condorelli M. Studies on the pathophysiology of aspirin idiosyncrasy. In: Bonomo L, Tursi A, eds. Recent advances in allergology. Florence: O.I.C. Medical Press; 1986: 77–97.

    Google Scholar 

  92. Wojnar RJ, Hearn T, Starkweather S. Augmentation of allergic histamine release from human leukocytes by nonsteroidal anti-inflammatory analgesic agents. J Allergy Clin Immunol 1980; 66: 37.

    Article  PubMed  CAS  Google Scholar 

  93. Mayer RJ, Marshall LA. New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and — nonselective enzymes. FASEB J 1993; 7: 339.

    PubMed  CAS  Google Scholar 

  94. Hamasaki Y, Kitzler J, Hardman R, Nettesheim P, Eling TE. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophys 1993; 304: 226.

    Article  PubMed  CAS  Google Scholar 

  95. Swingle KF, Moore GGI, Grant TJ. 4-Nitro-2-phenoxymethasulfonanilide (R-805): a chemically novel anti-inflammatory agent. Arch Int Pharmacodyn Ther 1976; 221: 132.

    PubMed  CAS  Google Scholar 

  96. Marino O, Casolaro V, Meliota S, Stellato C, Guidi G, Marone G. Inhibition of histamine release from human FcεRI+ cells by nimesulide. Agents Actions 1992; 32: C311.

  97. Casolaro V, Meliota S, Marino O, Patella V, de Paulis A, Guidi G, Marone G. Nimesulide, a sulfonanilide non-steroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. J Pharmacol Exp Ther 1993; 267: 1375.

    PubMed  CAS  Google Scholar 

  98. Andri L, Senna G, Betteli C, Givanni S, Scaricabarozzi I, Mezzelani P, Andri G. Tolerability of nimesulide in aspirin-sensitive patients. Ann Allergy 1994; 72: 29.

    PubMed  CAS  Google Scholar 

  99. Patella V, Ciccarelli A, Lamparter-Schummert B, de Paulis A, Adt M, Marone G. Heterogeneous effects of protamine on human mast cells and basophils. Br J Anaesth 1997; 78: 724.

    PubMed  CAS  Google Scholar 

  100. Ward A, Brogden RN. Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs 1988; 36: 732.

    Article  PubMed  CAS  Google Scholar 

  101. Bakhle YS, Botting RM. Cyclooxygenase-2 and its regulation in inflammation. Mediators Inflammation 1996; 5: 305.

    Article  CAS  Google Scholar 

  102. Spangler RS. Cyclooxygenase 1 and 2 in rheumatic diseases: implications for nonsteroidal anti-inflammatory drug therapy. Semin Arthritis Rheum 1996; 26: 435.

    Article  PubMed  CAS  Google Scholar 

  103. Schleimer RP, Hamid Q. Regulation of allergic airways inflammation by cytokines and glucocorticoids. In: Marone G, Austen KF, Holgate ST, Kay AB, Lichtenstein LM, eds. Asthma and allergic diseases. Physiology, immunopharmacology and treatment. London: Academic Press; 1998: 337–355.

    Google Scholar 

  104. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806.

    PubMed  CAS  Google Scholar 

  105. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, Assoufi B, Collins JV, Durham S, Kay AB. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407.

    PubMed  CAS  Google Scholar 

  106. Marone G, Casolaro V, Spadaro G, Genovese A. Bronchoalveolar lavage. In: Weiss EB, Stein M, eds. Bronchial asthma. Mechanism and therapeutics. Boston: Little Brown; 1993: 309–313.

    Google Scholar 

  107. Dunsky EH, Zweiman B, Fisher E, Levy DA. Early effects of corticosteroids on basophils, leukocyte histamine, and tissue histamine. J Allergy Clin Immunol 1979; 63: 426.

    Article  PubMed  CAS  Google Scholar 

  108. Lavker RM, Schechter NM. Cutaneous mast cell depletion results from topical corticosteroid usage. J Immunol 1985; 135: 2368.

    PubMed  CAS  Google Scholar 

  109. Schleimer RP, Lichtenstein LM, Gillespie E. Inhibition of basophil histamine release by anti-inflammatory steroids. Nature 1981; 292: 454.

    Article  PubMed  CAS  Google Scholar 

  110. Stellato C, Casolaro V, Renda A, Genovese A, Marone G. Anti-inflammatory effect of deflazacort. Int Arch Allergy Immunol 1992; 99: 340.

    Article  CAS  Google Scholar 

  111. Marone G, Stellato C, Renda A, Genovese A. Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophils. Eur J Clin Pharmacol 1993; 45 [Suppl 1]: S17.

  112. Schleimer RP, Schulman ES, MacGlashan DW Jr, Peters SP, Hayes EC, Adams GK III, Lichtenstein LM, Adkinson NF Jr. Effects of dexamethasone on mediator release from human lung fragments and purified lung mast cells. J Clin Invest 1983; 71: 1830.

    Article  PubMed  CAS  Google Scholar 

  113. Schleimer RP, Gillespie E, Lichtenstein LM. Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response. J Immunol 1981; 126: 570.

    PubMed  CAS  Google Scholar 

  114. Patella V, Casolaro V, Ciccarelli A, Pettit GR, Columbo M, Marone G. The antineoplastic bryostatins affect human basophils and mast cells differently. Blood 1995; 85: 1272.

    PubMed  CAS  Google Scholar 

  115. Nakamura S, Nishizuka Y. Lipid mediators and protein kinase C activation for the intracellular signaling network. J Biochem 1994; 115: 1029.

    PubMed  CAS  Google Scholar 

  116. Chang E-Y, Szallasi Z, Ács P, Raizada V, Wolfe PC, Fewtrell C, Blumberg PM, Rivera J. Functional effects of overexpression of protein kinase C-α, -β, -δ, -ε, and-η in the mast cell line RBL-2H3. J Immunol 1997; 159: 2624.

    PubMed  CAS  Google Scholar 

  117. Beaven MA, Rogers J, Moore JP, Hesketh TR, Smith GA, Metcalfe JC. The calcium signal and correlation with histamine release in 2H3 cells. J Biol Chem 1984; 259: 7129.

    PubMed  CAS  Google Scholar 

  118. Warner JA, MacGlashan DW Jr. Protein kinase C (PKC) changes in human basophils: IgE-mediated activation is accompanied by an increase in total PKC activity. J Immunol 1989; 142: 1669.

    PubMed  CAS  Google Scholar 

  119. White KN, Metzger H. Translocation of protein kinase C in rat basophilic leukemic cells induced by phorbol ester or by aggregation of IgE receptors. J Immunol 1988; 141: 942.

    PubMed  CAS  Google Scholar 

  120. Warner JA, MacGlashan DW Jr. Signal transduction events in human basophils: a comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formylmethionyl-leucyl-phenylalanine. J Immunol 1990; 145: 1897.

    PubMed  CAS  Google Scholar 

  121. Massey WA, Cohan VL, MacGlashan DW Jr, Gittlen SW, Kagey-Sobotka A, Lichtenstein LM, Warner JA. Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition. J Pharmacol Exp Ther 1991; 258: 824.

    PubMed  CAS  Google Scholar 

  122. Coussens L, Parker PJ, Rhee L, Yang-Feng TL, Chen E, Waterfield MD, Francke U, Ullrich A. Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signalling pathways. Science 1986; 233: 859.

    Article  PubMed  CAS  Google Scholar 

  123. Miura K, MacGlashan DW Jr. Expression of protein kinase C isozymes in human basophils: regulation by physiological and non-physiological stimuli. Blood. In press.

  124. Bergstrand H, Lundquist B, Karabelas K, Michelsen P. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor. J Pharmacol Exp Ther 1992; 260: 1028.

    PubMed  CAS  Google Scholar 

  125. Benhamou M, Gutkind JS, Robbins KC, Siraganian RP. Tyrosine phosphorylation coupled to IgE receptor mediated signal transduction and histamine release. Proc Natl Acad Sci USA 1990; 87: 5327.

    Article  PubMed  CAS  Google Scholar 

  126. Lavens SE, Peachell PT, Warner JA. Role of tyrosine kinases in IgE-mediated signal transduction in human lung mast cells and basophils. Am J Respir Cell Mol Biol 1992; 7: 637.

    PubMed  CAS  Google Scholar 

  127. Borel JF. Comparative study in vitro and in vivo drug effects on cell-mediated cytotoxicity. Immunology 1976; 31: 631.

    PubMed  CAS  Google Scholar 

  128. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 1992; 339: 324.

    Article  PubMed  CAS  Google Scholar 

  129. Pasero G, Priolo F, Marubini E, Fantini F, Ferraccioli G, Magaro M, Marcolongo R, Oriente P, Pipitone V, Portioli I, Tirri G, Trotta F, Della Casa-Alberighi O. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996; 39: 1006.

    Article  PubMed  CAS  Google Scholar 

  130. Hait WN, Harding MW, Handschumacher RE. Calmodulin, cyclophilin, and cyclosporin A. Science 1986; 233: 987.

    Article  PubMed  CAS  Google Scholar 

  131. Standaert RF, Galat A, Verdine GL, Schreiber SL. Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature 1990; 346: 671.

    Article  PubMed  CAS  Google Scholar 

  132. Jin Y-J, Albers MW, Lane WS, Bierer BE, Schreiber SL, Burakoff SJ. Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein. FKBP-13. Proc Natl Acad Sci USA 1991; 88: 6677.

    Article  PubMed  CAS  Google Scholar 

  133. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66: 807.

    Article  PubMed  CAS  Google Scholar 

  134. O’Keefe SJ, Tamura J, Kincaid RL, Tocci MJ, O’Neill EA. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature 1992; 357: 692.

    Article  PubMed  CAS  Google Scholar 

  135. Marone G, Triggiani M, Cirillo R, Giacummo A, Siri L, Condorelli M. Cyclosporin A (CsA) inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells. Ric Clin Lab 1988; 18: 53.

    Article  PubMed  CAS  Google Scholar 

  136. Cirillo R, Triggiani M, Siri L, Ciccarelli A, Pettit GR, Condorelli M, Marone G. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol 1990; 144: 3891.

    PubMed  CAS  Google Scholar 

  137. Stellato C, de Paulis A, Ciccarelli A, Cirillo R, Patella V, Casolaro V, Marone G. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 1992; 98: 800.

    Article  PubMed  CAS  Google Scholar 

  138. de Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A, Marone G. Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 1992; 99: 723.

    Article  PubMed  Google Scholar 

  139. Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabtree GR. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992; 358: 70.

    Article  PubMed  CAS  Google Scholar 

  140. Triggiani M, Cirillo R, Lichtenstein LM, Marone G. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by cyclosporin A. Int Arch Allergy Appl Immunol 1989; 88: 253.

    PubMed  CAS  Google Scholar 

  141. Marone G, de Paulis A, Ciccarelli A, Casolaro V, Spadaro G, Cirillo R. In vitro and in vivo characterization of the anti-inflammatory effects of cyclosporin A. Int Arch Allergy Immunol 1992; 99: 279.

    CAS  Google Scholar 

  142. Ruzicka T, Bieber T, Schöpf E, Rubins A, Dobozy A, Bos JD, Jablonska S, Ahmed I, Thestrup-Pedersen K, Daniel F, Finzi A, Reitamo S. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 1997; 337: 816.

    Article  PubMed  CAS  Google Scholar 

  143. Mitchell EB, Crow J, Chapman MD, Jouhal SS, Pope FM, Platts-Mills TAE. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982; I: 127.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marone, G., Spadaro, G., De Marino, V. et al. Immunopharmacology of human mast cells and basophils. Int J Clin Lab Res 28, 12–22 (1998). https://doi.org/10.1007/s005990050012

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005990050012

Key words

Navigation